Researchers find way to decrease cancer deaths among Black people, begin new lung cancer clinical trial, use app to help people manage cancer, and employ games to reduce chemotherapy after-effects.
Read how scientists reduce infection risk after pancreatic surgery, discover the best cost-effective treatment for prostate cancer, learn which lung cancer patients have the most emergency department visits, and more.
Neeraj Agarwal, MD, led a global study analyzing the combination of two cancer drugs to treat metastatic prostate cancer. Results showed this reduces the risk of cancer progression by 55%.
This planned expansion in Utah County will make it easier for patients to access advanced cancer research and care, while providing more educational opportunities and engagement with the community.
The new treatment combines a modified cold virus injected directly into a tumor and an immunotherapy drug given intravenously. This breakthrough comes after many years of pre-clinical and clinical studies.
In February 2023, researchers at Huntsman Cancer Institute and the University of Utah used magnetic resonance imaging to locate tumors and high-intensity ultrasound to kill them without surgery.
Read about new melanoma treatment practices, how models provide information about a rare adrenal cancer, a potential oral medication for brain cancer, and clinical trials for cancer patients with HIV.
Read about cutting-edge cancer research centered around elephant genes, a new clinical trial, and grants to study vaccination hesitance in the Mountain West as well as chronic lymphocytic leukemia.
A horrific motorcycle accident may have saved Bruce Miller’s life. A 2003 crash led to Miller discovering he had kidney cancer but clinical trials and immunotherapy have kept him going.
Agarwal is recognized for his extraordinary volunteer service, engagement, and commitment to the field of oncology and most importantly, the patients he serves. “I feel very privileged and honored to...
The combination of two oral medications has shown positive results in people with prostate cancer, whose disease has spread to other parts of the body. Compared with XTANDI plus placebo...
The groundbreaking clinical trials happening here at the Huntsman Cancer Institute are saving lives, and it is made possible in part by people like you—our donors. For Samuel Cheshier, MD...
In 2015, the National Cancer Institute (NCI) awarded Huntsman Cancer Institute with its Comprehensive status. Huntsman Cancer Institute is the only NCI-designated Cancer Center in the Mountain West, meaning we...
The Lymphoma Research Foundation selected Daniel Ermann, MD, for the highly competitive Lymphoma Scientific Research Mentoring Program, class of 2023. The foundation awards a career development grant of $10,000 to...
